潜伏性結核検査では、結核感染症の一種である潜伏性結核を検出します。結核感染症の一種で、細菌が体内で休眠状態にある、つまり細菌が眠った状態で存在します。この感染症はツベルクリン皮膚検査（TST）によってのみ検出できます。それにもかかわらず、潜伏感染が活動性結核に進行する可能性は依然としてあります。HIV、薬物乱用、免疫系を損なう薬物などの他の疾患もリスクを高めます。
人口の高齢化、喫煙の増加、医薬品の研究開発の増加により、市場は今後数年間で上昇すると予想されます。LTBI 検査市場は 2023 年に 19 億 6,000 万ドルに達すると予測され、予測期間中のCAGRは5.95% と推定されます。
目次
Table of contents
1. Executive Summary
2. Introduction
2.1 Latent Tuberculosis Infection Testing: An Overview
2.1.1 Definition of Latent Tuberculosis Infection Testing
2.1.2 Elements of Latent TB
2.2 LTBI Testing Segmentation: An Overview
2.2.1 LTBI Testing Segmentation
3. Global Market Analysis
3.1 Global LTBI Testing Market: An Analysis
3.1.1 Global LTBI Testing Market: An Overview
3.1.2 Global LTBI Testing Market by Value
3.1.3 Global LTBI Testing Market by Type (Tuberculin Skin Test LTBI Testing and Interferon Gamma Released Assay (IGRA) LTBI Testing)
3.1.4 Global LTBI Testing Market by Region (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa)
3.2 Global LTBI Testing Market: Type Analysis
3.2.1 Global LTBI Testing Market by Type: An Overview
3.2.2 Global Tuberculin Skin Test LTBI Testing Market by Value
3.2.3 Global Interferon Gamma Released Assay (IGRA) LTBI Testing Market by Value
3.3 Global LTBI Testing Market Volume: An Analysis
3.3.1 Global LTBI Testing Market by Volume: An Overview
3.3.2 Global LTBI Testing Market by Volume
3.3.3 Global LTBI Testing Market Volume by Type (Tuberculin Skin Test LTBI Testing and Interferon Gamma Released Assay (IGRA) LTBI Testing)
3.3.4 Global LTBI Testing Market Volume by Region (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa)
3.4 Global LTBI Testing Market Volume: Type Analysis
3.4.1 Global LTBI Testing Market Volume by Type: An Overview
3.4.2 Global Tuberculin Skin Test LTBI Testing Market by Volume
3.4.3 Global Interferon Gamma Released Assay (IGRA) LTBI Testing Market by Volume
4. Regional Market Analysis
4.1 North America LTBI Testing Market: An Analysis
4.1.1 North America LTBI Testing Market: An Overview
4.1.2 North America LTBI Testing Market by Value
4.1.3 North America LTBI Testing Market by Region (The US, Canada, Mexico)
4.1.4 The US LTBI Testing Market by Value
4.1.5 Canada LTBI Testing Market by Value
4.1.6 Mexico LTBI Testing Market by Value
4.1.7 North America LTBI Testing Market by Volume: An Overview
4.1.8 North America LTBI Testing Market by Volume
4.1.9 North America LTBI Testing Market Volume by Region (The US, Canada, Mexico)
4.1.10 The US LTBI Testing Market by Volume
4.1.11 Canada LTBI Testing Market by Volume
4.1.12 Mexico LTBI Testing Market by Volume
4.2 Europe LTBI Testing Market: An Analysis
4.2.1 Europe LTBI Testing Market: An Overview
4.2.2 Europe LTBI Testing Market by Value
4.2.3 Europe LTBI Testing Market by Region (UK, Germany, France, Spain, and Rest of Europe)
4.2.4 Germany LTBI Testing Market by Value
4.2.5 United Kingdom LTBI Testing Market by Value
4.2.6 France LTBI Testing Market by Value
4.2.7 Italy LTBI Testing Market by Value
4.2.8 Spain LTBI Testing Market by Value
4.2.9 Rest of Europe LTBI Testing Market by Value
4.2.10 Europe LTBI Testing Market by Volume: An Overview
4.2.11 Europe LTBI Testing Market by Volume
4.2.12 Europe LTBI Testing Market Volume by Region (UK, Germany, France, Spain, and Rest of Europe)
4.2.13 Germany LTBI Testing Market by Volume
4.2.14 United Kingdom LTBI Testing Market by Volume
4.2.15 France LTBI Testing Market by Volume
4.2.16 Italy LTBI Testing Market by Volume
4.2.17 Spain LTBI Testing Market by Volume
4.2.18 Rest of Europe LTBI Testing Market by Volume
4.3 Asia Pacific LTBI Testing Market: An Analysis
4.3.1 Asia Pacific LTBI Testing Market: An Overview
4.3.2 Asia Pacific LTBI Testing Market by Value
4.3.3 Asia Pacific LTBI Testing Market by Region (China, Japan, and Rest of Asia Pacific)
4.3.4 China LTBI Testing Market by Value
4.3.5 Japan LTBI Testing Market by Value
4.3.6 Rest of Asia Pacific LTBI Testing Market by Value
4.3.7 Asia Pacific LTBI Testing Market by Volume: An Overview
4.3.8 Asia Pacific LTBI Testing Market by Volume
4.3.9 Asia Pacific LTBI Testing Market Volume by Region (China, Japan, and Rest of Asia Pacific)
4.3.10 China LTBI Testing Market by Volume
4.3.11 Japan LTBI Testing Market by Volume
4.3.12 Rest of Asia Pacific LTBI Testing Market by Volume
4.4 Middle East & Africa LTBI Testing Market: An Analysis
4.4.1 Middle East & Africa LTBI Testing Market: An Overview
4.4.2 Middle East & Africa LTBI Testing Market by Value
4.4.3 Middle East & Africa LTBI Testing Market by Volume: An Overview
4.4.4 Middle East & Africa LTBI Testing Market by Volume
4.5 Latin America LTBI Testing Market: An Analysis
4.5.1 Latin America LTBI Testing Market: An Overview
4.5.2 Latin America LTBI Testing Market by Value
4.5.3 Latin America LTBI Testing Market by Volume: An Overview
4.5.4 Latin America LTBI Testing Market by Volume
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on LTBI Testing Market
5.1.2 Impact of COVID-19 on Poverty Rate
5.1.3 Impact of COVID-19 on Geriatric Population & Latent TB Treatment
5.1.4 Post COVID-19 Impact on Global LTBI Market
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Aging Population
6.1.2 Upsurge in Cigarette Consumption
6.1.3 Surging Prevalence of HIV
6.1.4 Urbanization leading to Monitoring and Screening Procedures
6.1.5 Growth in Pharmaceutical Research and Development
6.2 Challenges
6.2.1 Multidrug Resistant Tuberculosis (MDR-TB)
6.2.2 Stringent Government Regulations
6.2.3 Lack of Laboratory Facilities
6.3 Market Trends
6.3.1 Increasing Healthcare Expenditure in Emerging Markets
6.3.2 Accelerating TB Funding
6.3.3 Line Probe Assays (LPAs)
6.3.4 Nucleic Acid Amplification Tests (NAATs)
6.3.5 Expansion of Advanced and Hybrid Technique
6.3.6 Escalating Government Initiatives
7. Competitive Landscape
7.1 Global LTBI Testing Market Players by Market Capitalization
7.2 Global LTBI Testing Market Players by R&D Comparison
8. Company Profiles
8.1 Qiagen N.V.
8.1.1 Business Overview
8.1.2 Business Strategy
8.2 Thermo Fisher Scientific Inc.
8.2.1 Business Overview
8.2.2 Operating Segment
8.2.3 Business Strategy
8.3 Bio-rad Laboratories, Inc.
8.3.1 Business Overview
8.3.2 Operating Segment
8.3.3 Business Strategy
8.4 Abbott Laboratories
8.4.1 Business Overview
8.4.2 Operating Segment
8.4.3 Business Strategy
8.5 Becton, Dickinson & Company
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy
8.6 BioMérieux SA
8.6.1 Business Overview
8.6.2 Operating Segment
8.6.3 Business Strategy
8.7 Roche Holdings AG
8.7.1 Business Overview
8.7.2 Operating Segment
8.7.3 Business Strategy
8.8 PerkinElmer, Inc.
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategy
8.9 Sanofi S.A.
8.9.1 Business Overview
8.9.2 Operating Segments
8.9.3 Business Strategy
8.10 Endo International plc
8.10.1 Business Overview
8.10.2 Operating Segment
8.10.3 Business Strategy
8.11 Cyrus Poonawalla Group (Serum Institute of India Pvt. Ltd.)
8.11.1 Business Overview
8.11.2 Business Strategy
8.12 Bruker Corporation
8.12.1 Business Overview
8.12.2 Operating Segment
8.12.3 Business Strategy
Table of Figures
Figure 1: Elements of Latent TB
Figure 2: LTBI Testing Segmentation
Figure 3: Global LTBI Testing Market by Value; 2017-2021 (US$ Billion)
Figure 4: Global LTBI Testing Market by Value; 2022-2027 (US$ Billion)
Figure 5: Global LTBI Testing Market by Type; 2021 (Percentage, %)
Figure 6: Global LTBI Testing Market by Region; 2021 (Percentage, %)
Figure 7: Global Tuberculin Skin Test LTBI Testing Market by Value; 2017-2021 (US$ Billion)
Figure 8: Global Tuberculin Skin Test LTBI Testing Market by Value; 2022-2027 (US$ Billion)
Figure 9: Global Interferon Gamma Released Assay (IGRA) LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 10: Global Interferon Gamma Released Assay (IGRA) LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 11: Global LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 12: Global LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 13: Global LTBI Testing Market Volume by Type; 2021 (Percentage, %)
Figure 14: Global LTBI Testing Market Volume by Region; 2021 (Percentage, %)
Figure 15: Global Tuberculin Skin Test LTBI Testing Market by Volume, 2017-2021 (Million)
Figure 16: Global Tuberculin Skin Test LTBI Testing Market by Volume, 2022-2027 (Million)
Figure 17: Global Interferon Gamma Released Assay (IGRA) LTBI Testing Market by Volume, 2017-2021 (Million)
Figure 18: Global Interferon Gamma Released Assay (IGRA) LTBI Testing Market by Volume, 2022-2027 (Million)
Figure 19: North America LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 20: North America LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 21: North America LTBI Testing Market by Region; 2021 (Percentage, %)
Figure 22: The US LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 23: The US LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 24: Canada LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 25: Canada LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 26: Mexico LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 27: Mexico LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 28: North America LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 29: North America LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 30: North America LTBI Testing Market Volume by Region; 2021 (Percentage, %)
Figure 31: The US LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 32: The US LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 33: Canada LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 34: Canada LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 35: Mexico LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 36: Mexico LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 37: Europe LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 38: Europe LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 39: Europe LTBI Testing Market by Region; 2021 (Percentage, %)
Figure 40: Germany LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 41: Germany LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 42: United Kingdom LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 43: United Kingdom LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 44: France LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 45: France LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 46: Italy LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 47: Italy LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 48: Spain LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 49: Spain LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 50: Rest of Europe LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 51: Rest of Europe LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 52: Europe LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 53: Europe LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 54: Europe LTBI Testing Market Volume by Region; 2021 (Percentage, %)
Figure 55: Germany LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 56: Germany LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 57: United Kingdom LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 58: United Kingdom LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 59: France LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 60: France LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 61: Italy LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 62: Italy LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 63: Spain LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 64: Spain LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 65: Rest of Europe LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 66: Rest of Europe LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 67: Asia Pacific LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 68: Asia Pacific LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 69: Asia Pacific LTBI Testing Market by Region; 2021 (Percentage, %)
Figure 70: China LTBI Testing Market by Value, 2017-2021 (US$ Million)
Figure 71: China LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 72: Japan LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 73: Japan LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 74: Rest of Asia Pacific LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 75: Rest of Asia Pacific LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 76: Asia Pacific LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 77: Asia Pacific LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 78: Asia Pacific LTBI Testing Market Volume by Region; 2021 (Percentage, %)
Figure 79: China LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 80: China LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 81: Japan LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 82: Japan LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 83: Rest of Asia Pacific LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 84: Rest of Asia Pacific LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 85: Middle East & Africa LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 86: Middle East & Africa LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 87: Middle East & Africa LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 88: Middle East & Africa LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 89: Latin America LTBI Testing Market by Value; 2017-2021 (US$ Million)
Figure 90: Latin America LTBI Testing Market by Value; 2022-2027 (US$ Million)
Figure 91: Latin America LTBI Testing Market by Volume; 2017-2021 (Million)
Figure 92: Latin America LTBI Testing Market by Volume; 2022-2027 (Million)
Figure 93: Global Poverty Rate, 2014-2021 (Percentage, %)
Figure 94: Global Aging Population - 60 and Above; 2014-2021(Billion)
Figure 95: Global Cigarette Consumption; 2017-2021 (Billion)
Figure 96: Global Number of People Living with HIV; 2000-2021 (Million)
Figure 97: Global Urban Population; 2016-2021 (Billion)
Figure 98: Global Pharmaceutical Research and Development Expenditures; 2021-2030 (US$ Billion)
Figure 99: Healthcare Expenditure by Region; 2019-2021(US$ Thousand)
Figure 100: The US Funding for Global Tuberculosis (TB); 2016-2021 (US$ Million)
Figure 101: Thermo Fisher Scientific Inc. Revenues by Segment; 2021 (Percentage, %)
Figure 102: Bio-rad Laboratories, Inc. Net Sales by Segment; 2021 (Percentage, %)
Figure 103: Abbott Laboratories Sales by Segment; 2021 (Percentage, %)
Figure 104: Becton, Dickinson & Company Revenues by Segment; 2021 (Percentage, %)
Figure 105: BioMérieux SA Sales by Segments; 2021 (Percentage, %)
Figure 106: Roche Holdings AG Revenues by Operating Segment; 2021 (Percentage, %)
Figure 107: PerkinElmer, Inc. Revenues by Operating Segments; 2021 (Percentage, %)
Figure 108: Sanofi S.A. Net Sales by Operating Segments; 2021 (Percentage, %)
Figure 109: Endo International plc Net Revenues by Segment; 2021 (Percentage, %)
Figure 110: Bruker Corporation Revenue by Segment; 2021 (Percentage, %)
Table 1: Current LPA products and Associated Equipment
Table 2: NAAT-based Technologies
Table 3: Global LTBI Testing Market Players by Market Capitalization; 2022 (US$ Billion)
Table 4: Global LTBI Testing Market Players by R&D Comparison; 2021 (US$ Billion)
